Durable Response With Single-Agent Acalabrutinib in Patients With Relapsed or Refractory Mantle Cell Lymphoma
Leukemia - United Kingdom
doi 10.1038/s41375-019-0575-9
Full Text
Open PDFAbstract
Available in full text
Date
September 26, 2019
Authors
Publisher
Springer Science and Business Media LLC